grepcent public filings, reorganized for comparison

FRAGMIN — FDA application NDA020287

Application NDA020287 · type NDA · FDA status: approved · original approval 1994-12-22

Listed sponsor: PFIZER · PFE company profile · exact_unique

Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.

FDA application facts

ProductFDA-listed trade nameActive ingredientDosage formRouteStrengthMarketing statusTE codeRLD
001FRAGMINDALTEPARIN SODIUMINJECTABLESUBCUTANEOUS2,500IU/0.2ML (12,500IU/ML)Prescriptionnot listedYes
002FRAGMINDALTEPARIN SODIUMINJECTABLESUBCUTANEOUS10,000IU/0.4ML (25,000IU/ML)Discontinuednot listedNo
003FRAGMINDALTEPARIN SODIUMINJECTABLESUBCUTANEOUS5,000IU/0.2ML (25,000IU/ML)Prescriptionnot listedYes
004FRAGMINDALTEPARIN SODIUMINJECTABLESUBCUTANEOUS10,000IU/ML (10,000IU/ML)Prescriptionnot listedYes
005FRAGMINDALTEPARIN SODIUMINJECTABLESUBCUTANEOUS7,500IU/0.3ML (25,000IU/ML)Prescriptionnot listedYes
006FRAGMINDALTEPARIN SODIUMINJECTABLESUBCUTANEOUS95,000IU/3.8ML (25,000IU/ML)Prescriptionnot listedYes
007FRAGMINDALTEPARIN SODIUMINJECTABLESUBCUTANEOUS95,000IU/9.5ML (10,000IU/ML)Discontinuednot listedNo
008FRAGMINDALTEPARIN SODIUMINJECTABLEINJECTION7,500 IU/0.75MLDiscontinuednot listedNo
009FRAGMINDALTEPARIN SODIUMINJECTABLESUBCUTANEOUS12,500IU/0.5ML (25,000IU/ML)Prescriptionnot listedYes
010FRAGMINDALTEPARIN SODIUMINJECTABLESUBCUTANEOUS15,000IU/0.6ML (25,000IU/ML)Prescriptionnot listedYes
011FRAGMINDALTEPARIN SODIUMINJECTABLESUBCUTANEOUS18,000IU/0.72ML (25,000IU/ML)Prescriptionnot listedYes
012FRAGMINDALTEPARIN SODIUMINJECTABLESUBCUTANEOUS10,000IU/4ML (2,500IU/ML)Prescriptionnot listedYes

Product, form, strength, reference-drug and marketing-status fields: Drugs@FDA data files; TE and RLD fields: Orange Book data files. Retrieved 2026-08-07.

Orange Book patent and exclusivity listings

No Orange Book patent or exclusivity listings joined to this application.

Compound cross-links

Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.

Related pages

Sponsor company · FDA-approved application index

Peer clusters: Large-cap biopharma

Sources: Drugs@FDA · Orange Book · openFDA application record. FDA data retrieved 2026-08-07.

Regulatory listing data as published by FDA; not medical or investment advice.